Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for relapsing-remitting forms of multiple sclerosis (MS)
June 2014
Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for relapsing-remitting forms of multiple sclerosis (MS) in Canada....
Exclusive Subscriber Content
- Best in class medication learning
- Concise recommendations
- Hundreds of practical resources
Login to access this content.
Login